News · PR
News · PR
The inauguration of the new president and CEO at Bushu Pharmaceuticals Ltd.
- Press Releases
November 21, 2019 – Bushu Pharmaceuticals Ltd. (Kawagoe, Saitama, Japan) , Jun Yokohama, Representative Director, President and CEO will leave the company on November 26, 2019. Mr. Tetsuichi Okada will be appointed as new Representative Director, President and CEO. The career of Mr. Tetsuichi Okada
SHIONOGI & CO., LTD.
: Manufacturing control manager
Bushu Pharmaceuticals Ltd.
: Director / General Manager of Manufacturing
: Director / Vice President, General Manager of Manufacturing
: Chairman of the board For further information, please contact to
Tadashi Iida, Marketing division
Phone:+81-0490273-6386 Email: tadashi.iida @bushu-seiyaku.co.jp
Address: 1 Takeno, Kawagoe, Saitama, 3500801, Japan About us:
Bushu Pharmaceuticals Ltd. was established in August 1998 as an independent pharmaceutical contract manufacturer. Bushu has capital of 1 billion yen. Bushu carries out contract manufacturing and packaging of clinical trials and commercial products in accordance with latest GMP standards. Through the utilization of know-how and latest industry information, Bushu prides itself in being able to offer added-value solutions to customers. For more information,
refer to our website: https://www.bushu-seiyaku.co.jp/en/
As a company specializing in contract manufacturing of pharmaceutical drugs, we offer a wide range of contract services tailored to clients’ needs based on our extensive experience and know-how accumulated over many years.